2 news items
Elicio Therapeutics Unveils Promising Phase 1a Data For ELI-002 7P In mKRAS Tumors
ELTX
10 Jun 24
science, immunology and oncology, it plans to forge a new path forward for cancer treatment by utilizing its diverse capabilities to fulfill its mission
Elicio Therapeutics Celebrates 13 Years Developing Innovative Cancer Immunotherapies
ELTX
24 Apr 24
. The company was founded in 2011 with the mission to leverage novel MIT research for cancer vaccine development. Now enrolling a Phase 2 trial with its
- Prev
- 1
- Next